Agilent Technologies Setting New Standards in Mass Spectrometry, Lab Productivity

Agilent Technologies Inc. (NYSE: A) today announced it will introduce a new range of laboratory solutions at the Korean Society for Mass Spectrometry (KSMS) 2014, Aug. 20-22. The new collection of instruments, software and services is intended to help scientists and researchers in Korea push the boundaries of achievement and transform laboratory productivity.

The new solutions include the Agilent 7010 Triple Quadrupole GC/MS System, a high-efficiency electron ionization (EI) source that enables attogram detection limits. This capability is an industry-first for an EI GC/MS/MS system. The improved sensitivity means lower detection limits, increased confidence in results at all measurement levels, and the ability for users to significantly streamline sample preparation procedures. This is the first significant innovation for EI design in decades and is valued by lab professionals challenged by stringent regulatory guidelines and ever-increasing workloads.

The new flagship triple-quadrupole mass spectrometer for LC/MS applications, the Agilent 6495 LC/MS Triple Quadrupole system, will also be showcased. This is a high-performance instrument designed for both routine laboratory analysis and the most challenging quantitation in life sciences, food and environmental applications. Laboratories can use it to screen, identify and quantitate multiple pesticide residues. Pharmaceutical researchers can use it for rigorous drug and protein quantitation.

“As the global leader in mass spectrometry, Agilent continually delivers innovations with powerful and reliable solutions that can be used in diverse applications such as pharmaceutical, food safety, environmental, forensic, metabolomic, metallomic and proteomic analysis and clinical research,” said

Si-Young Park, Agilent’s country general manager in South Korea.

Other new solutions that will be discussed with customers and partners at KSMS 2014 include:

• The Agilent 6120VL, an entry-level mass detector based on the company’s proven single-quadrupole LC/MS technology. This new affordable single-quadrupole MS system is fully integrated with Agilent’s UHPLC systems and will allow academic, industrial and pharmaceutical laboratories to benefit from the analytical advantages of mass detection.
• Software capabilities for control of supercritical fluid chromatography (SFC/MS) in all of Agilent’s LC/MS instruments. Used together, these hardware-software solutions for SFC/MS will further streamline the high-volume analysis of complex samples, making them ideal for use in pharmaceutical, food science, lipodomic, metabolomic, environmental and petrochemical industries. Agilent now supports the full range of separation techniques - GC, CE, LC and SFC on a single software platform.
• The new MassHunter Quantitative Analysis software with Target Deconvolution for users to effectively remove background matrix ions from data and easily produce targeted quantitative and qualitative results from complex samples.
• New application-specific LC columns to help increase laboratory throughput and provide rapid, reproducible, high-resolution results for critical applications. The AdvanceBio Glycan Mapping Column is designed to deliver fast, high-resolution glycan separations, while the Poroshell HPH-C18 and Poroshell HPH-C8 chemistries are ideal for high-pH applications.
• Two new solutions for automated protein sample preparation - the AssayMAP Phosphopeptide Enrichment Solution and the Affinity Purification Workflow Solution. These are designed to help customers optimize even the most challenging protein sample preparation workflows.
• An addition to Agilent’s full line of pesticide monitoring and analysis solution, the new Personal Compound Database and Library is for use with GC/Q-TOF mass spectrometers. This full-spectrum Pesticide PCDL enables clear and decisive identification of even the most challenging pesticides and unknown contaminants.

KSMS 2014, the industry’s leading annual conference, is organized by the Korean Society for Mass Spectrometry to encourage knowledge-sharing among the country’s top scientists and researchers and to expand the application of mass spectrometry in various fields. The conference is held at the Jeju International Convention Center on Jeju Island, South Korea. Agilent will be at booths 1-3 at the Convention Center’s Samda Hall. As a Diamond sponsor of KSMS 2014, Agilent will also host a user meeting on Aug. 20 and a luncheon seminar on Aug. 21.

“We look forward to meeting with our customers and partners in South Korea to share our new innovations and further discuss their needs as they push the boundaries of science and technology to improve the quality of life,” said Park.

Agilent Technologies Inc. (NYSE: A) is a leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.

In September 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. On Aug. 1, 2014, the company’s electronic measurement business began operating as Keysight Technologies, Inc., a wholly owned subsidiary. The separation is expected to be completed in early November 2014.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the separation of Agilent’s electronic measurement business; future revenues, earnings and profitability; the future demand for the company’s products and services; and customer expectations. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of our customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; customer purchasing decisions and timing, and the risk that we are not able to realize the savings expected from integration and restructuring activities.

In addition, other risks that Agilent faces include those detailed in Agilent’s filings with the Securities and Exchange Commission, including our latest Form 10-K and Form 10-Q. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

# # #